Acasti Pharma Financials
ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Acasti |
Understanding current and past Acasti Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Acasti Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Acasti Pharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Acasti Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acasti Pharma. Check Acasti Pharma's Beneish M Score to see the likelihood of Acasti Pharma's management manipulating its earnings.
Acasti Pharma Stock Summary
Acasti Pharma competes with Tonix Pharmaceuticals, Jaguar Animal, Ibio, Akari Therapeutics, and Aditxt. Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | CA00430K8730 |
Business Address | 103 Carnegie Center, |
New Symbol | GRCE |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.acastipharma.com |
Phone | 818 839 4378 |
Currency | USD - US Dollar |
Acasti Pharma Key Financial Ratios
Return On Equity | -0.19 | |||
Return On Asset | -0.12 | |||
Target Price | 7.97 | |||
Beta | 1.52 |
Acasti Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Acasti Pharma's current stock value. Our valuation model uses many indicators to compare Acasti Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acasti Pharma competition to find correlations between indicators driving Acasti Pharma's intrinsic value. More Info.Acasti Pharma is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Acasti Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Acasti Pharma Market Pulse
Quote | 3.37 |
Change(%) | 0.30 |
Change | 0.01 |
Open | 3.38 |
Low | 3.2 |
High | 3.45 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Acasti Pharma is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Acasti has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Acasti Pharma's financials are consistent with your investment objective using the following steps:- Review Acasti Pharma's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Acasti Pharma's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Acasti Pharma's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Acasti Pharma's stock is overvalued or undervalued.
Acasti Pharma November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Acasti Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Acasti Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Acasti Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Acasti Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Acasti Pharma's daily price indicators and compare them against related drivers.
Downside Deviation | 3.1 | |||
Information Ratio | 0.0512 | |||
Maximum Drawdown | 25.09 | |||
Value At Risk | (3.85) | |||
Potential Upside | 9.42 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Acasti Stock
If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stocks Directory Find actively traded stocks across global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Money Managers Screen money managers from public funds and ETFs managed around the world |